company background image
1066 logo

Shandong Weigao Group Medical Polymer SEHK:1066 Voorraadrapport

Laatste prijs

HK$5.92

Marktkapitalisatie

HK$27.0b

7D

0.3%

1Y

12.3%

Bijgewerkt

16 May, 2025

Gegevens

Financiële gegevens bedrijf +

Shandong Weigao Group Medical Polymer Company Limited

SEHK:1066 Voorraadrapport

Marktkapitalisatie: HK$27.0b

1066 Overzicht aandelen

Shandong Weigao Group Medical Polymer Company Limited houdt zich bezig met onderzoek en ontwikkeling, productie, groothandel en verkoop van medische hulpmiddelen in de Volksrepubliek China. Meer informatie

Beloningen

Verhandeld tegen 53.9% onder onze schatting van de reële waarde

De winst zal naar verwachting met 8.48% per jaar groeien

De winst is de afgelopen 5 jaar met 1.2% per jaar gegroeid

Handelen tegen een goede waarde vergeleken met branchegenoten en branchegenoten

Risicoanalyse

Onstabiel dividend track record


Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

Shandong Weigao Group Medical Polymer Company Limited Concurrenten

Shanghai Conant Optical

SEHK:2276

HK$11.9b

Kangji Medical Holdings

SEHK:9997

HK$9.4b

China Isotope & Radiation

SEHK:1763

HK$3.7b

Shanghai INT Medical Instruments

SEHK:1501

HK$4.7b

Prijsgeschiedenis en prestaties

Overzicht van hoogtepunten, dieptepunten en veranderingen in de aandelenkoersen voor Shandong Weigao Group Medical Polymer
Historische aandelenkoersen
Huidige aandelenkoersHK$5.92
52 Week HoogtepuntHK$6.54
52 Week LaagHK$3.60
Bèta0.50
1 maand verandering7.83%
3 maanden verandering19.35%
1 Jaar Verandering12.33%
3 jaar verandering-31.48%
5 jaar verandering-54.60%
Verandering sinds IPO3,331.88%

Recent nieuws en updates

Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

May 06
Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

Analysts Are Updating Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Estimates After Its Annual Results

Mar 28
Analysts Are Updating Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Estimates After Its Annual Results

Recent updates

Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

May 06
Shandong Weigao Group Medical Polymer (HKG:1066) Seems To Use Debt Rather Sparingly

Analysts Are Updating Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Estimates After Its Annual Results

Mar 28
Analysts Are Updating Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Estimates After Its Annual Results

Pinning Down Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) P/E Is Difficult Right Now

Mar 10
Pinning Down Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) P/E Is Difficult Right Now

Shandong Weigao Group Medical Polymer (HKG:1066) Is Reinvesting At Lower Rates Of Return

Feb 07
Shandong Weigao Group Medical Polymer (HKG:1066) Is Reinvesting At Lower Rates Of Return

Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Nov 26
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital

Nov 04
Be Wary Of Shandong Weigao Group Medical Polymer (HKG:1066) And Its Returns On Capital

Analysts Have Been Trimming Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Price Target After Its Latest Report

Sep 24
Analysts Have Been Trimming Their Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Price Target After Its Latest Report

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target

Aug 30
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Just Reported, And Analysts Assigned A HK$6.74 Price Target

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk

Jun 25
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) 27% Share Price Plunge Could Signal Some Risk

Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return

Jun 23
Here's What To Make Of Shandong Weigao Group Medical Polymer's (HKG:1066) Decelerating Rates Of Return

Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year

May 31
Shandong Weigao Group Medical Polymer's (HKG:1066) Shareholders Will Receive A Bigger Dividend Than Last Year

We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope

May 22
We Think Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) CEO Compensation Package Needs To Be Put Under A Microscope

Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Apr 23
Earnings Not Telling The Story For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Mar 28
Analysts Have Lowered Expectations For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) After Its Latest Results

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Jan 09
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Shares May Have Run Too Fast Too Soon

Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Dec 22
Returns On Capital Are Showing Encouraging Signs At Shandong Weigao Group Medical Polymer (HKG:1066)

Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Nov 10
Are Investors Undervaluing Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) By 44%?

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Oct 05
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Aug 01
Return Trends At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Appealing

Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Jul 19
Is Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Trading At A 28% Discount?

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Jun 22
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

Jun 09
Is Shandong Weigao Group Medical Polymer (HKG:1066) Using Too Much Debt?

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Apr 27
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

Mar 17
Shandong Weigao Group Medical Polymer (HKG:1066) Ticks All The Boxes When It Comes To Earnings Growth

A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Feb 27
A Look At The Intrinsic Value Of Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)

Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Jan 18
Returns On Capital At Shandong Weigao Group Medical Polymer (HKG:1066) Have Hit The Brakes

Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Dec 12
Does Shandong Weigao Group Medical Polymer (HKG:1066) Have A Healthy Balance Sheet?

Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Nov 29
Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Shares Could Be 21% Below Their Intrinsic Value Estimate

Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Nov 14
Here's Why We Think Shandong Weigao Group Medical Polymer (HKG:1066) Might Deserve Your Attention Today

Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

Oct 03
Shandong Weigao Group Medical Polymer (HKG:1066) Is Paying Out A Larger Dividend Than Last Year

The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Sep 21
The Returns At Shandong Weigao Group Medical Polymer (HKG:1066) Aren't Growing

Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Sep 05
Shandong Weigao Group Medical Polymer (HKG:1066) Could Easily Take On More Debt

Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Aug 23
Shandong Weigao Group Medical Polymer Company Limited's (HKG:1066) Intrinsic Value Is Potentially 27% Above Its Share Price

Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

Aug 08
Here's Why Shandong Weigao Group Medical Polymer (HKG:1066) Has Caught The Eye Of Investors

There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Jun 22
There's Been No Shortage Of Growth Recently For Shandong Weigao Group Medical Polymer's (HKG:1066) Returns On Capital

Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

Jun 08
Shandong Weigao Group Medical Polymer (HKG:1066) Will Pay A Smaller Dividend Than Last Year

An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

May 16
An Intrinsic Calculation For Shandong Weigao Group Medical Polymer Company Limited (HKG:1066) Suggests It's 27% Undervalued

Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

May 03
Is Shandong Weigao Group Medical Polymer (HKG:1066) A Risky Investment?

Rendement voor aandeelhouders

1066HK Medical EquipmentHK Markt
7D0.3%-2.2%3.0%
1Y12.3%2.7%12.2%

Rendement versus industrie: 1066 overtrof de Hong Kong Medical Equipment industrie, die het afgelopen jaar een rendement 2.7 % opleverde.

Rendement versus markt: 1066 kwam overeen met de Hong Kong markt, die het afgelopen jaar een rendement opleverde van 12.2 %.

Prijsvolatiliteit

Is 1066's price volatile compared to industry and market?
1066 volatility
1066 Average Weekly Movement7.4%
Medical Equipment Industry Average Movement9.2%
Market Average Movement8.0%
10% most volatile stocks in HK Market15.4%
10% least volatile stocks in HK Market4.2%

Stabiele aandelenkoers: 1066 heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend vergeleken met de Hong Kong markt.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 7% ) van 1066 is het afgelopen jaar stabiel geweest.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
198812,719Rinan Congwww.weigaogroup.com

Shandong Weigao Group Medical Polymer Company Limited houdt zich bezig met onderzoek en ontwikkeling, productie, groothandel en verkoop van medische hulpmiddelen in de Volksrepubliek China. Het bedrijf is actief via de segmenten Medical Device Products, Orthopedic Products, Pharma Packaging Products, Interventional Products, Blood Management Products en Others. Het segment Medical Device Products omvat veilige infusie, klinische verpleging, perioperatieve, endocriene, urinaire, revalidatiesysteem en extracorporale circulatieoplossingen.

Shandong Weigao Group Medical Polymer Company Limited Samenvatting

Hoe verhouden de winst en inkomsten van Shandong Weigao Group Medical Polymer zich tot de beurswaarde?
1066 fundamentele statistieken
MarktkapitalisatieHK$27.03b
Inkomsten(TTM)HK$2.24b
Inkomsten(TTM)HK$14.20b

12.1x

Koers/Winstverhouding

1.9x

P/S-verhouding

Is 1066 overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
1066 resultatenrekening (TTM)
InkomstenCN¥13.09b
Kosten van inkomstenCN¥6.55b
BrutowinstCN¥6.54b
Overige uitgavenCN¥4.47b
InkomstenCN¥2.07b

Laatst gerapporteerde inkomsten

Dec 31, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)0.45
Brutomarge49.94%
Nettowinstmarge15.79%
Schuld/Eigen Vermogen Verhouding15.8%

Hoe presteerde 1066 op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

3.9%

Huidig dividendrendement

47%

Uitbetalingsratio

Betaalt 1066 een betrouwbaar dividend?

Zie 1066 dividendgeschiedenis en benchmarks
Wanneer moet je 1066 kopen om een aanstaand dividend te ontvangen?
Shandong Weigao Group Medical Polymer dividenddata
Ex Dividend DatumJun 02 2025
Betaaldatum dividendJul 11 2025
Dagen tot Ex-dividend16 days
Dagen tot dividendbetaaldatum55 days

Betaalt 1066 een betrouwbaar dividend?

Zie 1066 dividendgeschiedenis en benchmarks

Bedrijfsanalyse en status van financiële gegevens

GegevensLaatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse2025/05/16 19:32
Aandelenkoers aan het einde van de dag2025/05/16 00:00
Inkomsten2024/12/31
Jaarlijkse inkomsten2024/12/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

PakketGegevensTijdframeVoorbeeld Amerikaanse bron *
Financiële gegevens bedrijf10 jaar
  • Resultatenrekening
  • Kasstroomoverzicht
  • Balans
Consensus schattingen analisten+3 jaar
  • Financiële prognoses
  • Koersdoelen analisten
Marktprijzen30 jaar
  • Aandelenprijzen
  • Dividenden, splitsingen en acties
Eigendom10 jaar
  • Top aandeelhouders
  • Handel met voorkennis
Beheer10 jaar
  • Leiderschapsteam
  • Raad van bestuur
Belangrijkste ontwikkelingen10 jaar
  • Bedrijfsaankondigingen

* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.

Bronnen van analisten

Shandong Weigao Group Medical Polymer Company Limited wordt gevolgd door 33 analisten. 8 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

AnalistInstelling
Jason MannBarclays
Derrick SunBNP Paribas Securities (Asia)
Jessica LiBofA Global Research